Gema Carrasco

Mrs. Gema Carrasco

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in New Microbes and New Infections
Verified
Journal Article
Open access
JSJ.A. Sáez-Nieto
J.A. Sáez-Nieto
MMM.J. Medina-Pascual
M.J. Medina-Pascual
GCGema Carrasco
Gema Carrasco
NGN. Garrido
N. Garrido
MFM.A. Fernandez-Torres
M.A. Fernandez-Torres
SVSylvia Valdezate
Sylvia Valdezate
One hundred thirty-six isolates, 88 human and 48 environmental, that met the requirements to belong to the genus Paenibacillus were identified using a polyphasic taxonomic approach known as 16S rRNA plus phenotypic traits. Thirty-seven Paenibacillus species were identified; some had not been previously reported from clinical samples. The main species were P. pabuli (13 isolates), P. provencensis (11), P. phoenicis (9) and P. lautus (8). P. pabuli (11/13) and P. provencensis (8/11) were mainly environmental isolates, while P. phoenicis (9/9) and P. lautus (6/8) were mainly human isolates. Despite the difficulties in assigning to human Paenibacillus isolates a role as a pathogen or contaminant, here 25% of the isolates were involved in true infections, especially in those cases that affected abscesses, wound exudates, ocular infections and diverse fluids. In addition, 15 isolates were identified as 11 'Candidatus' to a new species, all of them from human specimens except one that was obtained from laboratory air. The antimicrobial susceptibility testing showed 95.6% of isolates were resistant to ampicillin, 44% were resistant to cotrimoxazole, 20 to 30% were resistant to cefotaxime and vancomycin and 13% were resistant to rifampicin and erythromycin.

15 December 2016 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Closed access
PDF file
SVSylvia Valdezate
Sylvia Valdezate
NGNoelia Garrido
Noelia Garrido
GCGema Carrasco
Gema Carrasco
MMMaría J. Medina-Pascual
María J. Medina-Pascual
PVPilar Villalón
Pilar Villalón
JSJuan A. Saéz-Nieto
Juan A. Saéz-Nieto
Objectives: The aims of this study were to explore the clinical distribution, by species, of the genus Nocardia and to assess the antimicrobial susceptibilities of the 10 most prevalent species identified in Spain. Methods: Over a 10 year period (2005–14), 1119 Nocardia strains were molecularly identified and subjected to the Etest. The distribution and resistance trends over the sub-periods 2005–09 and 2010–14 were also examined. Results: Of the strains examined, 82.9% belonged to the following species: Nocardia cyriacigeorgica (25.3%), Nocardia nova (15.0%), Nocardia abscessus (12.7%), Nocardia farcinica (11.4%), Nocardia carnea (4.3%), Nocardia brasiliensis (3.5%), Nocardia otitidiscaviarum (3.1%), Nocardia flavorosea (2.6%), Nocardia rhamnosiphila (2.6%) and Nocardia transvalensis (2.4%). Their prevalence values were similar during 2005–09 and 2010–14, except for those of N. abscessus, N. farcinica and N. transvalensis, which fell significantly in the second sub-period (P ≤ 0.05). The major location of isolation was the respiratory tract (∼86%). Half (13/27) of all strains from the CNS were N. farcinica. Significant differences in MIC results were recorded for some species between the two sub-periods. According to the CLSI’s breakpoints, low resistance rates (≤15%) were recorded for seven species with respect to cefotaxime, imipenem and tobramycin; five species showed similar rates with respect to trimethoprim/sulfamethoxazole. Linezolid and amikacin were the most frequently active agents. Conclusion: The accurate identification of the infecting species and the determination of its susceptibility to antimicrobial agents, given the large number of strains with atypical patterns, are crucial if patients with nocardiosis are to be successfully treated.

9 November 2012 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
PVPilar Villalón
Pilar Villalón
SVSylvia Valdezate
Sylvia Valdezate
MMMaria J. Medina-Pascual
Maria J. Medina-Pascual
GCGema Carrasco
Gema Carrasco
AVAna Vindel
Ana Vindel
JSJuan A. Saez-Nieto
Juan A. Saez-Nieto
To study the distribution, diversity and activity of Acinetobacter-derived cephalosporinase (ADC)-, carbapenem-hydrolysing oxacillinase (CHO)- and metallo-β-lactamase (MBL)-encoding genes, and of the most common insertion sequences (ISs), in the genome of nosocomial, epidemic, multidrug-resistant Acinetobacter baumannii (MDRAB) clones from Spain. The studied population included 59 MDRAB strains previously genotyped by PFGE and multilocus sequence typing. The search for the ADC (blaADC), CHO (blaOXA-51-like, blaOXA-23-like, blaOXA-40-like and blaOXA-58-like) and MBL (blaIMP, blaVIM, blaSIM-1, blaGIM-1, blaSPM-1 and blaNDM-1) genes, and for the ISs (ISAba1, ISAba2, ISAba3, ISAba4 and IS18) was done by PCR assays. The phenotypic presence of MBL enzymes was examined using imipenem/imipenem + EDTA strips. The most prevalent IS, ISAba1 (93.2%), was detected upstream of blaADC and blaOXA-51-like. These genes showed ample diversity (10 and 8 alleles, respectively). Four ADC sequences (ADC-1-likeP240S, ADC-2-likeN260H/T264N, ADC-11-likeQ163K and ADC-11-likeG342R) are described here for the first time. blaOXA-58-like was carried by 20.3% of strains, in association with ISAba2, ISAba3 or IS18. blaOXA-40-like was the most prevalent acquired CHO gene (57.6%), and was associated with none of the studied ISs. Neither blaOXA-23-like nor ISAba4 was detected in any strain. Some 67.8% of strains with MBL activity showed no corresponding gene in PCR; these results were more common in strains with a highly active CHO, such as OXA-40. All the studied genes and their related ISs showed a clonal distribution. Imipenem resistance was probably provided by OXA-40 for the most part, while MBL- and OXA-23-encoding genes were absent in the studied population.

1 November 2013 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
PDF file
GCGema Carrasco
Gema Carrasco
SVSylvia Valdezate
Sylvia Valdezate
NGNoelia Garrido
Noelia Garrido
PVPilar Villalón
Pilar Villalón
MMMaria J. Medina-Pascual
Maria J. Medina-Pascual
JSJuan A. Sáez-Nieto
Juan A. Sáez-Nieto
This study compares the identification, typing, and phylogenetic relationships of the most prevalent clinical Nocardia species in Spain, as determined via sequence analysis of their housekeeping genes gyrB and rpoB , with the results returned by the gold standard 16S rRNA method. gyrB and rpoB analyses identified Nocardia abscessus , N. cyriacigeorgica , N. farcinica , and the N. nova complex, species that together account for more than half of the human nocardiosis cases recorded in Spain. The individual discriminatory power of gyrB and rpoB with respect to intraspecies typing, calculated using the Hunter-Gaston discriminatory index (HGDI), was generally high (HGDI, 0.85 to 1), except for rpoB with respect to N. farcinica (HGDI, 0.71). Phylogenetically, different degrees of intra- and interspecies microheterogeneity were observed for gyrB and rpoB in a group of 119 clinical strains. A single 16S haplotype was obtained for each species, except for the N. nova complex (8 types), while gyrB and rpoB were more polymorphic: N. abscessus had 14 and 18 haplotypes, N. cyriacigeorgica had 17 and 12, N. farcinica had 11 and 5, and the N. nova complex had 26 and 29 haplotypes, respectively. A diversity gradient was therefore seen, with N. farcinica at the bottom followed by N. abscessus and N. cyriacigeorgica in the middle and N. nova complex at the top. The complexity of the N. nova complex is highlighted by its six variations in the GyrB 126 AAAPEH motif. gyrB sequencing (with or without rpoB sequencing) offers a simple means for identifying the most prevalent Nocardia species in Spanish medical laboratories and for determining the intraspecific diversity among their strains.

28 April 2015 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
SVSylvia Valdezate
Sylvia Valdezate
NGNoelia Garrido
Noelia Garrido
GCGema Carrasco
Gema Carrasco
PVPilar Villalón
Pilar Villalón
MMMaría J. Medina-Pascual
María J. Medina-Pascual
JSJuan A. Saéz-Nieto
Juan A. Saéz-Nieto
The soil-borne pathogen Nocardia spp. causes severe cutaneous, pulmonary and central nervous system infections. Against them, co-trimoxazole (SXT) constitutes the mainstay of antimicrobial therapy. However, some Nocardia strains show resistance to SXT, but the underlying genetic basis is unknown. We investigated the presence of genetic resistance determinants and class 1-3 integrons in 76 SXT-resistant Nocardia strains by PCR and sequencing. By E-test, these clinical strains showed SXT MICs of ≥32:608 mg/L (ratio of 1:19 for trimethoprim: sulfamethoxazole). They belonged to 12 species, being the main representatives N. farcinica (32%), followed by N. flavorosea (6.5%), N. nova (11.8%), N. carnea (10.5%), N. transvalensis (10.5%) and Nocardia spp. (6.5%). The prevalence of resistance genes in the SXT-resistant strains was as follows: sul1 and sul2 93.4% and 78.9% respectively, dfrA(S1) 14.7%, blaTEM-1 and blaZ 2.6% and 2.6% respectively, VIM-2 1.3%, aph(3´)-IIIa 40.8%, ermA, ermB, mefA and msrD 2.6%, 77.6%, 14.4%, and 5.2% respectively, and tet(O), tet(M), and tet(L) 48.6%, 25.0% and 3.9% respectively. Detected amino acid changes in GyrA were not related to fluoroquinolone resistance, but probably linked to species polymorphism. Class 1 and 3 integrons were found in 93.42% and 56.57% strains, respectively. Class 2 integrons and sul3 genes were not detected. Other mechanisms, different than dfrA(S1), dfrD, dfrF, dfrG and dfrK, could explain the strong trimethoprim resistance shown by the other 64 strains. For first time, resistance determinants commonly found in clinically important bacteria were detected in Nocardia spp. sul1, sul2, erm(B) and tet(O) were the most prevalent in the SXT-resistant strains. The similarity in their resistome could be due to a common genetic platform, in which these determinants are co-transferred

27 May 2021 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
PVPilar Villalón
Pilar Villalón
JSJuan A Sáez-Nieto
Juan A Sáez-Nieto
VRVirginia Rubio-López
Virginia Rubio-López
MMM. J. Medina-Pascual
M. J. Medina-Pascual
NGNoelia Garrido
Noelia Garrido
SVSylvia Valdezate
Sylvia Valdezate